0001144204-13-016159.txt : 20130319 0001144204-13-016159.hdr.sgml : 20130319 20130319163318 ACCESSION NUMBER: 0001144204-13-016159 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130315 FILED AS OF DATE: 20130319 DATE AS OF CHANGE: 20130319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KENNEDY WILLIAM JAMES CENTRAL INDEX KEY: 0001448888 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 13702195 MAIL ADDRESS: STREET 1: C/O XTL BIOPHARMACEUTICALS LTD STREET 2: 711 EXECUTIVE BLVD., SUITE Q CITY: VALLEY COTTAGE STATE: NY ZIP: 10989 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 787 SEVENTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 4 1 v338554_4.xml OWNERSHIP DOCUMENT X0306 4 2013-03-15 0 0001001316 TG THERAPEUTICS, INC. TGTX 0001448888 KENNEDY WILLIAM JAMES 787 SEVENTH AVENUE 48TH FLOOR NEW YORK NY 10019 1 0 0 0 COMMON STOCK 2013-03-15 4 A 0 8881 0 A 58881 D Reflects a grant of restricted shares that will vest on April 16, 2015. /s/ William J. Kennedy 2013-03-19